Total bilirubin =< 1.5 times upper limit of normal (ULN)
Total bilirubin =< 2 mg/dL or =< 1.5 times upper limit of normal (ULN)
Total bilirubin =< 1.5 times institutional upper limit of normal (ULN)
Total bilirubin < 1 times the upper limit of normal
Total bilirubin =< 2.5 times upper limit of normal AND
total bilirubin ? 3 times the upper limit of normal (ULN)
Serum total bilirubin =< 2.0 times the upper limit of normal
Total bilirubin =< 1.5 times the institutional upper limit of normal (ULN) OR direct bilirubin =< the normal in subjects with total bilirubin > 1.5 times the ULN
Total bilirubin =< 1.5 times upper limit of normal (ULN)
Total bilirubin < 1.5 times upper limit of normal for age and documented within 14 days prior to registration and within 14 days prior to the start of treatment
Documented within 14 days of registration: Total bilirubin < 1.5 times upper limit of normal for age
Total bilirubin =< 1.5 times upper limit of normal\r\n* If transaminase elevation and/or bilirubin elevation is attributed to the presence of liver metastases, a total bilirubin =< 2.5 times the upper limit of normal and an aspartate aminotransferase (AST) and alanine aminotransferase (ALT) =< 2.5 times the upper limit of normal are permissible; patients with an elevated bilirubin level that is attributed to an inherited disorder, such as Gilbert’s disease, may be enrolled at the discretion of the principal investigator
Total bilirubin >1.5 times upper limit of normal (ULN)
Total bilirubin < 1.5 times upper limit of institutional normal
PHASE I: Total bilirubin =< 1.5 times upper limit of normal (ULN)
PHASE IB: Total bilirubin =< 1.5 times upper limit of normal (ULN)
Total bilirubin =< 1.5 times institutional upper limit of normal (ULN)
INCLUSION CRITERIA FOR STRATUM C: Total bilirubin =< 1.5 times institutional upper limit of normal (ULN)
Total bilirubin =< 1.5 times upper limit of institutional normal (ULN) for age
Total bilirubin =< 2.5 times upper limit of normal
total bilirubin ? 2 times the upper limit of normal (ULN)
Total bilirubin (TBL) > 2.5 times the upper limit of normal at the screening visit
Total bilirubin < 3.0 times the institutional upper limit of normal (ULN)
Total bilirubin < 2.0 times the institutional upper limit of normal (ULN)
Total bilirubin =< 1.5 times the upper limit of the reference range
Total serum bilirubin =< 1.5 times upper limit of normal (ULN).
Total bilirubin =< 1.5 times upper limit of normal (ULN).
Total bilirubin less than 2 mg/dL or 1.5 times upper limit of normal (ULN)
Total bilirubin =< 1.5 times the institutional upper limit of normal.
Total bilirubin =< 1.5 times the upper limit of normal (ULN)
Total bilirubin =< 1.5 times upper limit of normal (x ULN).
Within two weeks prior to enrollment: Total bilirubin =< 1.5 times the upper limit of normal
Total bilirubin < 1.5 times upper limit of normal for age, within 14 days of registration and within 7 days of the start of treatment
Total bilirubin (Tbili) > 1.5 times the upper limit of normal at the screening visit
Total bilirubin =< 1.5 times upper limit of normal (ULN)
Total bilirubin > 2 times the upper limit of normal OR in patients with Gilbert’s syndrome, a total bilirubin > 3.0
Total bilirubin ? 3 times the upper limit of normal (ULN)
Total bilirubin =< 1.5 times the upper limit of the institutional normal values
Total bilirubin greater than 2.5 times the upper limit of normal
Total serum bilirubin =< 1.5 times upper limit of normal (ULN)
Total bilirubin =< 1.5 times upper limit of (institutional/central) normal (patients with Gilbert’s syndrome total bilirubin must be =< 4 times institutional upper limit of normal)
Total bilirubin =< 1.5 times upper limit of normal (ULN)
Bilirubin (total) > 1.5 times the upper limit of normal
Completed within 60 days of surgery: Total bilirubin < 1.5 times the upper limit of institutional normal value
Total bilirubin =< 2 mg/dL; serum transaminases less than two times the institutional upper limit of normal (< 2 x upper limit of normal [ULN])
Serum total bilirubin > 1.5 times the upper limit of normal (ULN);
Total bilirubin =< 1.5 times upper limit of normal (ULN)
Total bilirubin of =< 1.5 times upper limit of normal (exception is made for patients with Gilbert’s syndrome who may be considered eligible if total bilirubin is < 3 times upper limit of normal)
Total serum bilirubin =< 1.5 times the upper limit of normal
EXCLUSION CRITERIA FOR ADDITIONAL PTCy-MILs INFUSION AT RELAPSE: Total bilirubin > 3 times the upper limit of normal (ULN)
Within 21 days prior to course 1 day 1 (C1D1): Total bilirubin < 2 times the upper limit of normal (ULN)
Total bilirubin =< 1.5 times the institutional upper limit of normal
Total bilirubin =< 1.5 times the upper limit of normal (ULN) (to be performed within 7 days prior to start of study treatment)
Total bilirubin < 2.0 times the institutional upper limit of normal (ULN)
Total bilirubin =< 3 times the upper limit of normal if patient had recent biliary stenting and a falling trend in bilirubin is demonstrated such that capecitabine treatment is deemed feasible per the treating medical oncologist, total bilirubin =< 1.5 times the upper limit of normal if no biliary stenting was done
Total bilirubin < 1.5 times upper limit of normal
Total bilirubin =< 2 times the upper limit of normal (ULN)
Total bilirubin < 1.5 times upper limit of normal
Total bilirubin =< 1.5 times the upper limit of normal (ULN)
Total bilirubin < 2.0 times the institutional upper limit of normal (ULN)
Total bilirubin =< 1.5 times institutional upper limit of normal (ULN)
Total bilirubin =< 1.5 times upper limit of normal for age
Total bilirubin =< 1.5 times upper limit of normal range
Total bilirubin =< 2 times the upper limit of normal (ULN) (except patients with Gilbert’s syndrome who must have a total bilirubin of < 3 times ULN)
Total bilirubin =< 1.5 times upper limit of normal (ULN) within 28 days prior to registration.
Total bilirubin < 1.5 times upper limit of normal
Serum total bilirubin and liver enzymes are 2 times the upper limit of normal
Total bilirubin =< 1.5 times upper limit of normal (ULN)
Total bilirubin =< 1.5 times upper limit of normal (ULN)
Total bilirubin =< 1.5 times upper limit of normal (ULN)
Total bilirubin =< 1.5 times institutional upper limit of normal (ULN)
Total bilirubin =< 1.5 times upper limit of normal (ULN)
Total bilirubin level >= 1.5 times the upper limit of normal (ULN) (except patients with Gilbert syndrome, who are excluded if total bilirubin >= 3 times ULN), or
Total bilirubin =< 1.5 times upper limit of normal (ULN) for age
Total bilirubin within =< 1.5 times the upper limit of normal (ULN) institutional limits
Total bilirubin < 1.5 times upper limit of institutional normal
Total bilirubin =< 1.5 times upper limit of normal (ULN)
Total bilirubin =< 1.5 times the upper limit of normal (ULN)
Total bilirubin < 2 times the upper limit of normal (ULN) (except patients with Gilbert’s syndrome who must have a total bilirubin of < 3 times ULN)
Total serum bilirubin of less than 3 times the upper limit of normal
Total bilirubin =< 2 mg/dL or =< 1.5 times upper limit of normal (ULN)
Total bilirubin =< 1.5 times institutional upper limit of normal (ULN)
PHASE II: Total bilirubin =< 1.5 times institutional upper limit of normal (ULN)
Total bilirubin < 1.5 times the institutional upper limit of normal (ULN); subjects with Gilbert’s syndrome and total bilirubin >= 1.5 times the upper limit of normal are eligible to participate
Total serum/plasma bilirubin ?1.5 times the upper limit of normal (ULN).
Total bilirubin ? 1.5 times the upper limit of normal;
Total bilirubin ? 3 times upper limit of normal (ULN) for age
Total bilirubin =< 1.25 times upper limit of normal
Total bilirubin =< 1.5 times the upper limit of normal
Total bilirubin =< 2.5 times upper limit of normal; AND
Total bilirubin > 3 times the upper limit of normal
Total bilirubin within 1.5 times the institutional upper limit of normal (ULN)
Total bilirubin =< 1.5 times institutional upper limit of normal (ULN)
Total bilirubin =< 1.5 times the upper limit of normal (ULN) unless due to Gilbert’s disease or hemolysis, then =< 3.0 times ULN
Total bilirubin > 3 times the upper limit of normal
Total bilirubin < 2 times the upper limit of normal (ULN) (except patients with Gilbert’s syndrome who must have a total bilirubin of < 3 times ULN)
Bilirubin < 2 times the upper limit of normal (ULN) (except patients with Gilbert’s syndrome who must have a total bilirubin of < 3 times ULN)
Total bilirubin < 1.5 times the upper limit of normal (x ULN) for the institution
Bilirubin < 2 times the upper limit of normal (ULN) (except patients with Gilbert’s syndrome who must have a total bilirubin of < 3 times ULN)
Serum total bilirubin =< 2 times the upper limit of normal
Total bilirubin =< 1.5 times ULN (upper limit of normal)
Total bilirubin > 2.5 times the upper limit of normal
Total bilirubin =< 1. 5 times the institutional upper limit of normal
Total bilirubin =< 1.5 times the upper limit of normal (ULN)
Total bilirubin > 1.5 times upper normal limit (unless due to chronic GVHD)
Total bilirubin < 2.0 times the institutional upper limit of normal (ULN)
Total bilirubin =< 2 times upper limit of normal
Total bilirubin =< 1.5 times the upper limit of normal within two weeks prior to enrollment
Total bilirubin within 1.5 times the upper limit of normal institutional limits
Total bilirubin < 2.0 times the institutional Upper Limit of Normal (ULN)
Total and direct bilirubin < 1.5 times upper limit of laboratory normal
Total bilirubin < 1.5 times upper limit of normal (ULN), except patients with Gilbert's syndrome who must have total bilirubin of < 3 times ULN
Total bilirubin ?2 times the upper limit of normal (× ULN)
Total bilirubin ? 1.5 times the upper limit of normal (ULN)
Total bilirubin =< 1.5 times the upper limit of normal (ULN)
Total bilirubin =< 1.5 times the upper limit of normal (ULN)
Total bilirubin </=1.5 times the upper limit of normal (ULN)
Total bilirubin =< 1.5 times the institutional upper limit of normal
Patients must have adequate hepatic function with a total bilirubin =< 1.5 times upper limit normal (ULN) within one week prior to treatment
RECURRENT/ PROGRESSIVE DIPG (STRATUM 1): Total bilirubin =< 1.5 times institutional upper limit of normal (ULN)
NON-PROGRESSED DIPG (STRATUM 2): Total bilirubin =< 1.5 times institutional upper limit of normal (ULN)
Total bilirubin < 2 times the upper limit of normal (ULN) (except patients with Gilbert’s syndrome who must have a total bilirubin of < 3 times ULN)
Total bilirubin </=1.5 times the upper limit of normal (ULN)
Inadequate liver function as indicated by total bilirubin >= 1.5 times the upper limit of normal
Total bilirubin less than 1.5 times upper limit of normal (ULN), or less than 3 times ULN at study entry in a patient with documented Gilbert’s disease
Total bilirubin =< 1.5 times institutional upper limit of normal (ULN)
Total bilirubin ? 3 times the upper limit of normal (ULN)
Total bilirubin =< 1.5 times upper limit of normal (ULN)
Total bilirubin =< 1.5 times the upper limit of normal for age
Total bilirubin =< 1.5 times upper limit of normal (ULN) for age
Total bilirubin >= 1.5 times upper limit of normal (ULN)
Total bilirubin < 2 times the upper limit of normal
Total bilirubin =< 1.5 times upper limit of normal
Total bilirubin < 2 times the upper limit of normal (ULN) (except patients with Gilbert’s syndrome who must have a total bilirubin of < 3 times ULN)
Total bilirubin ? 2.5 times upper limit of normal (ULN);
Total bilirubin =< 1.5 times upper limit of normal (ULN) OR direct bilirubin normal (per institute standards)
Total serum bilirubin < 2 times upper limit of normal
Total bilirubin greater than 2 times upper limit of normal
Total bilirubin must be < 2.0 times the upper limit of the institutional normal range; test results must be no more than 3 months old
Total bilirubin must be < 1.5 times the upper limit of normal
Minocycline trial only: screening results for total bilirubin must be < 2 times the upper limit of normal
Patient with total bilirubin three times the upper limit of normal
Total bilirubin must be < 1.5 times the upper limit of normal, as evidenced in laboratory values =< 3 months old
Total bilirubin level =< 1.5 times upper limit of normal (ULN)
Total bilirubin within 1.5 times the institution’s upper limit of normal (ULN)
SUB-STUDY I: Total bilirubin > 3 times the upper limit of normal
SUB-STUDY II: Total bilirubin > 3 times the upper limit of normal
SUB-STUDY III: Total bilirubin > 3 times the upper limit of normal
Total bilirubin > 2 times the upper limit of normal
Total bilirubin > 2 times the upper limit of normal
Total bilirubin > 3 times the upper limit of normal
Bilirubin (total) less than 4.0 times below or above the upper or lower limit range
Total bilirubin less than 4.0 times below or above the upper or lower limit range
Total bilirubin > 2 times the upper limit of normal
Total bilirubin ?1.5 times the upper limit of normal (ULN)
Total bilirubin ? 1.5 times the upper limit of normal (ULN). For intrahepatic cholangiocarcinoma (IHCC) patients only, total bilirubin ? 2.5 times ULN is acceptable
